Literature DB >> 9531033

Platelet cNOS activity is reduced in patients with IDDM and NIDDM.

V Martina1, G A Bruno, F Trucco, E Zumpano, M Tagliabue, C Di Bisceglie, G Pescarmona.   

Abstract

Several studies in vitro and in vivo suggest that the nitric oxide (NO) production is impaired in diabetes mellitus. Reduced levels of NO could contribute to vascular alteration facilitating platelet-vascular wall interaction, adhesion of monocytes to endothelium, vascular smooth muscle proliferation and by decreasing endothelium-dependent vasodilation. In this study we evaluated the activity of the constitutive nitric oxide synthase (cNOS) in platelets of patients with insulin-dependent diabetes mellitus (IDDM) and with non-insulin-dependent diabetes mellitus (NIDDM). When compared to that of normal subjects, cNOS activity is significantly lower in patients with IDDM and with NIDDM (1.57 +/- 0.25 vs. 0.66 +/- 0.10 fmol/min/10(9) PLTs and 1.57 +/- 0.25 vs. 0.67 +/- 0.08, respectively; p<0.005). These data demonstrate that the platelet cNOS activity is decreased in diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9531033

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  8 in total

1.  Administration of glutathione in patients with type 2 diabetes mellitus increases the platelet constitutive nitric oxide synthase activity and reduces PAI-1.

Authors:  V Martina; G A Bruno; E Zumpano; C Origlia; L Quaranta; G P Pescarmona
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

2.  Changes in the Plasma and Platelet Nitric Oxide Biotransformation Metabolites during Ischemic Stroke-A Dynamic Human LC/MS Metabolomic Study.

Authors:  Maciej Bladowski; Ewa Szahidewicz-Krupska; Jerzy Wiśniewski; Paulina Fortuna; Justyna Chojdak-Łukasiewicz; Slawomir Budrewicz; Mariusz Fleszar; Adrian Doroszko
Journal:  Antioxidants (Basel)       Date:  2022-05-12

3.  Prolonged treatment with N-acetylcysteine and L-arginine restores gonadal function in patients with polycystic ovary syndrome.

Authors:  A Masha; C Manieri; S Dinatale; G A Bruno; E Ghigo; V Martina
Journal:  J Endocrinol Invest       Date:  2009-04-15       Impact factor: 4.256

4.  Nitric oxide generation mediated by beta-adrenoceptors is impaired in platelets from patients with Type 2 diabetes mellitus.

Authors:  L R Queen; Y Ji; I Goubareva; A Ferro
Journal:  Diabetologia       Date:  2003-10-23       Impact factor: 10.122

5.  N-acetylcysteine is able to reduce the oxidation status and the endothelial activation after a high-glucose content meal in patients with Type 2 diabetes mellitus.

Authors:  A Masha; L Brocato; S Dinatale; C Mascia; F Biasi; V Martina
Journal:  J Endocrinol Invest       Date:  2009-04       Impact factor: 4.256

6.  Increased Intraplatelet ADMA Level May Promote Platelet Activation in Diabetes Mellitus.

Authors:  Jakub Gawryś; Jerzy Wiśniewski; Ewa Szahidewicz-Krupska; Damian Gajecki; Julia Leśniewska; Filip Majda; Karolina Gawryś; Paulina Fortuna; Piotr Mlynarz; Adrian Doroszko
Journal:  Oxid Med Cell Longev       Date:  2020-09-29       Impact factor: 6.543

7.  Exercise training enhanced myocardial endothelial nitric oxide synthase (eNOS) function in diabetic Goto-Kakizaki (GK) rats.

Authors:  James Grijalva; Steven Hicks; Xiangmin Zhao; Sushma Medikayala; Pawel M Kaminski; Michael S Wolin; John G Edwards
Journal:  Cardiovasc Diabetol       Date:  2008-11-19       Impact factor: 9.951

Review 8.  Body temperature regulation in diabetes.

Authors:  Glen P Kenny; Ronald J Sigal; Ryan McGinn
Journal:  Temperature (Austin)       Date:  2016-01-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.